Literature DB >> 5449702

Evidence for suppression of parathyroid gland activity by hypermagnesemia.

S G Massry, J W Coburn, C R Kleeman.   

Abstract

The effect of hypermagnesemia, produced by MgCl(2) infusion, on the activity of parathyroid glands, as assessed by changes in levels of serum calcium (S(Ca)) and in the fraction of filtered phosphate excreted (C(P)/C(Cr)), was studied in 11 intact and 4 thyroparathyroidectomized (T-PTX) dogs. To exclude the effect of diurnal variation in C(P)/C(Cr) on the results, studies were initiated in both morning and afternoon hours and each study with MgCl(2) infusion was paired with a control experiment in the same dog not receiving MgCl(2). During MgCl(2) infusion, serum phosphorus rose progressively. Despite this rise, the levels of C(P)/C(Cr) fell in all experiments and were significantly different from values observed at the same time of the day in the paired control experiments. The concentrations of total S(Ca) fell by 1.0-2.4 mg/100 ml with a proportional decrease in the levels of the diffusible and ionized fractions. The pattern of the fall in C(P)/C(Cr) during MgCl(2) resembled that observed after CaCl(2) infusion (seven dogs) and that which acutely followed thyroparathyroidectomy (seven dogs). When parathyroid extract was given to dogs receiving MgCl(2) infusion both C(P)/C(Cr) and S(Ca) rose, and MgCl(2) infusion did not affect C(P)/C(Cr) and S(Ca) in T-PTX dogs. These results indicate that hypermagnesemia suppresses the activity of the parathyroid glands, probably, by inhibiting production and (or) release of the hormone, without interfering with end-organ response. An increase in serum magnesium of 1.7-2.0 mg/100 ml was capable of producing the suppressive effect. Evaluation of the effect of simultaneous modest hypocalcemia and hypermagnesemia suggests that a decrease in the level of serum calcium is more potent than an increase in the concentration of serum magnesium in the regulation of parathyroid activity.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5449702      PMCID: PMC322645          DOI: 10.1172/JCI106379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Observations in experimental magnesium depletion.

Authors:  R WHANG; L G WELT
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

2.  Interrelations of magnesium, phosphate and calcium metabolism.

Authors:  B L ARDILL; J A HALLIDAY; J D MORRISON; H C MULHOLLAND; R A WOMERSLEY
Journal:  Clin Sci       Date:  1962-08       Impact factor: 6.124

3.  Interrelation between renal transport systems of magnesium and calcium.

Authors:  A H SAMIY; J L BROWN; D L GLOBUS; R H KESSLER; D D THOMPSON
Journal:  Am J Physiol       Date:  1960-03

4.  Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes.

Authors:  L C CHESLEY; I TEPPER
Journal:  J Clin Invest       Date:  1958-10       Impact factor: 14.808

Review 5.  Thyrocalcitonin.

Authors:  P F Hirsch; P L Munson
Journal:  Physiol Rev       Date:  1969-07       Impact factor: 37.312

6.  Inhibition of parathyroid gland activity by hypermagnesemia.

Authors:  H J Gitelman; S Kukolj; L G Welt
Journal:  Am J Physiol       Date:  1968-08

7.  The influence of plasma magnesium concentration on parathyroid hormone secretion.

Authors:  R M Buckle; A D Care; C W Cooper; H J Gitelman
Journal:  J Endocrinol       Date:  1968-12       Impact factor: 4.286

Review 8.  Parathyroid hormone.

Authors:  C D Arnaud; A M Tenenhouse; H Rasmussen
Journal:  Annu Rev Physiol       Date:  1967       Impact factor: 19.318

9.  Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness.

Authors:  H Estep; W A Shaw; C Watlington; R Hobe; W Holland; S G Tucker
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

10.  The influence of the parathyroid glands on the hypercalcemia of experimental magnesium depletion in the rat.

Authors:  H J Gitelman; S Kukolj; L G Welt
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

View more
  19 in total

1.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

2.  The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism.

Authors:  I R Gough; G A Balderson; H M Lloyd; J Galligan; D Willgoss; B G Fryar
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Simultaneous Mg, Ca, P,K,Na and Cl analysis in rat tubular fluid. II. During acute Mg plasma loading.

Authors:  C Le Grimellec; N Roinel; F Morel
Journal:  Pflugers Arch       Date:  1973-05-23       Impact factor: 3.657

Review 4.  The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. I.

Authors:  C R Kleeman; S G Massry; J W Coburn
Journal:  Calif Med       Date:  1971-03

Review 5.  Renal handling of calcium and phosphate.

Authors:  F Lang
Journal:  Klin Wochenschr       Date:  1980-10-01

6.  Case report: Primary (autoimmune?) parathyroiditis.

Authors:  M Van de Casseye; W Gepts
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973-11-27

7.  Hypermagnesaemia and hypophosphataemia after ingestion of magnesium sulphate.

Authors:  P Garcia-Webb; C Bhagat; T Oh; G Hart; W Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

8.  Suppression of parathyroid gland activity by magnesium. Morphometric ultrastructural study.

Authors:  E Altenähr; F Leonhardt
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

9.  Influence of magnesium on the secretion and action of parathyroid hormone.

Authors:  K S Nair; I M Holdaway; M C Evans; A D Cameron
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

10.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.